Novo Settles Drug Marketing Claims For $26.7M
Novo Nordisk Inc. announced Friday that it would pay $26.7 million to resolve federal investigations and False Claims Act lawsuits in New York and Maryland brought by former employees and a...To view the full article, register now.
Already a subscriber? Click here to view full article